Optical imaging platform to unravel metabolic reprogramming of cancer: a path for improved treatments

Project Information

METABOLIGHT

Grant agreement ID: 866338

DOI

10.3030/866338

Project terminated on 31 January 2024

EC signature date 12 February 2020

Start date 1 June 2020

End date 31 May 2025

Funded under

• EXCELLENT SCIENCE - European Research Council (ERC)

Total cost

€ 1 997 375,00

EU contribution

€ 1 997 375,00

Coordinated by

SWISSLUMIX SARL
Switzerland

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (1)

A bioluminescent-based probe for in vivo non-invasive monitoring of nicotinamide riboside uptake reveals a link between metastasis and NAD+ metabolism

Author(s): Tamara Maric, Arkadiy Bazhin, Pavlo Khodakivskyi, Georgy Mikhaylov, Ekaterina Solodnikova, Aleksey Yevtodiyenko, Greta Maria Paola Giordano Attianese, George Coukos, Melita Irving, Magali Joffraud, Carles Cantó, Elena Goun.
Published in: Biosensors and Bioelectronics, 2023, ISSN 0956-5663
Publisher: Pergamon Press Ltd.